Celldex Therapeutics | CLDX - Attività

Prezzo Delle Azioni
33.20
Cambio Giornaliero
0.79 2.44%
Mensile
8.04%
Annuale
102.32%
Q2 Previsione
30.13




Attività Cambiamento Data
AbbVie USD 133.96B 62M 2025-12
Agenus USD 226.8M 7.09M 2025-12
Amgen USD 90.59B 445M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Celldex Therapeutics USD 582.98M 65.46M 2025-12
Glaxosmithkline GBP 82.34B 102.25M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Northwest Biotherapeutics USD 30.61M 1.06M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12